:: CLDF - Chronic Liver Disease Foundation ::

	Single Disease Educational Content






	Multi-Disease Educational Content



	Other Resources







	About CLDF

Back

Bruce R. Bacon, MD has received research support from Roche Laboratories, Gilead, Sciences, Bristol-Myers Squibb, Vertex and speaker/consulting support from the following: Gilead Sciences and Vertex.

Willis C. Maddrey, MD has received consulting support from the following: Schering, Pfizer, Novartis, Bristol-Myers Squibb.

F. Fred Poordad, MD has received grants/research support and/or consultant support from the following: Schering, Roche, Bristol Myers Squibb, Gilead, Roche, and Vertex.

Eugene R. Schiff, MD has received consulting and/or research support from the following: Schering, Bayer Healthcare, Bristol Myers Squibb, Gilead, Roche, Salix, Vertex Pharmaceuticals.


Jointly sponsored by Purdue University School of Pharmacy and the Chronic Liver Disease Foundation
	This activity supported by: Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, Onyx Pharmaceuticals, Roche Pharmaceuticals, Salix Pharmaceuticals and Vertex Pharmaceuticals.

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.

for US healthcare providers only. Use of this Web site is governed by the CLD Foundation terms of use and privacy statement.

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.

for US healthcare providers only. Use of this Web site is governed by the CLD Foundation terms of use and privacy statement.